financetom
Business
financetom
/
Business
/
Market Chatter: JPMorgan Chase Eyeing Four-Part Bond Sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: JPMorgan Chase Eyeing Four-Part Bond Sale
Jul 15, 2024 7:23 AM

09:55 AM EDT, 07/15/2024 (MT Newswires) -- JPMorgan Chase ( JPM ) is selling bonds in as many as four parts, including an 11-year tranche, Bloomberg reported Monday, quoting an unnamed source with knowledge of the matter.

JP Morgan is the first of the six largest US banks to tap the investment-grade market after reporting Q2 earnings, the report said.

The 11-year tranche of JP Morgan's offering may yield 1.35 percentage point above Treasuries, Bloomberg reported.

JP Morgan didn't immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 207.99, Change: +3.05, Percent Change: +1.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial
Nov 13, 2025
Gilead Sciences Inc ( GILD ). on Thursday shared topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of HIV patients who are virologically suppressed switching from a multi-tablet regimen to an investigational single-tablet regimen of bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN). • GILD shares are testing new highs. Check the market position here....
Outlook Therapeutics' Biologics License Application Resubmission for ONS-5010 Accepted by FDA
Outlook Therapeutics' Biologics License Application Resubmission for ONS-5010 Accepted by FDA
Nov 13, 2025
01:51 PM EST, 11/13/2025 (MT Newswires) -- Outlook Therapeutics ( OTLK ) said Thursday that the US Food and Drug Administration accepted the resubmission of the Biologics License Application for ONS-5010, to be used for the treatment of wet age-related macular degeneration. The FDA has set a Prescription Drug User Fee Act goal date of Dec. 31, Outlook Therapeutics (...
Intuitive Surgical Insider Sold Shares Worth $435,000, According to a Recent SEC Filing
Intuitive Surgical Insider Sold Shares Worth $435,000, According to a Recent SEC Filing
Nov 13, 2025
01:58 PM EST, 11/13/2025 (MT Newswires) -- Craig H Barratt, Director, on November 12, 2025, sold 750 shares in Intuitive Surgical ( ISRG ) for $435,000. Following the Form 4 filing with the SEC, Barratt has control over a total of 27,198 common shares of the company, with 27,198 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1035267/000127762025000008/xslF345X05/edgardoc.xml Price: 568.86, Change: -3.60, Percent Change:...
Oil States International Adds Listing on NYSE Texas
Oil States International Adds Listing on NYSE Texas
Nov 13, 2025
01:49 PM EST, 11/13/2025 (MT Newswires) -- Oil States International ( OIS ) said Thursday that its common stock will begin trading on NYSE Texas, a new electronic exchange based in Dallas. The company will maintain its primary listing on New York Stock Exchange under the OIS ticker. Price: 6.27, Change: -0.06, Percent Change: -0.87 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved